Fiasp Vs. Humalog: Rapid-Acting Insulin Analogues For Diabetes Management
Both Fiasp and Humalog are rapid-acting insulin analogues used to control blood sugar levels in individuals with diabetes. Fiasp has a faster onset of action (5-15 minutes) compared to Humalog (15-30 minutes), which provides more flexibility in mealtime dosing. Fiasp also has a shorter duration of action (2-3 hours) than Humalog (3-4 hours), allowing for…